Page 2548 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2548

Chapter 157  Hematologic Manifestations of HIV/AIDS  2271


             TABLE   Agents for Treatment and Prevention of Opportunistic Infections With Hematologic Toxicities
              157.4
             Drug Class            Drug Toxicities                      Hematologic
             Antifungal agents     Amphotericin B deoxycholate and lipid   Anemia
                                     formulations
                                   Anidulafungin                        Deep vein thrombosis (rare)
                                   Flucytosine                          Bone marrow suppression
                                   Micafungin                           Hemolysis, leukopenia
             Anti-Pneumocystis     Dapsone                              Methemoglobinemia, hemolytic anemia (especially in patients
               pneumonia agents                                           with G6PD deficiency), neutropenia.
                                   Primaquine                           Methemoglobinemia, hemolytic anemia (especially in patients
                                                                          with G6PD deficiency).
                                   Trimethoprim-sulfamethoxazole (TMP-SMX)  Bone marrow suppression.
             Antitoxoplasmosis agents  Pyrimethamine                    Neutropenia, thrombocytopenia, megaloblastic anemia.
                                   Sulfadiazine                         Bone marrow suppression.
             Antimycobacterial agents  Rifampin                         Thrombocytopenia, hemolytic anemia.
                                   Rifabutin                            Neutropenia anemia, thrombocytopenia
             Antiviral agents      Ganciclovir                          Neutropenia, thrombocytopenia, anemia,
                                   Interferon-alfa and peginterferon-alfa  Neutropenia, thrombocytopenia.
                                   Ribavirin                            Hemolytic anemia.
                                   Valaciclovir                         At a high dose of 8 g/day: thrombotic thrombocytopenic purpura/
                                                                          hemolytic uremic syndrome reported in advanced human
                                                                          immunodeficiency virus patients and in transplant recipients
                                   Valganciclovir                       Neutropenia, thrombocytopenia, anemia.
             Antiparasitic agents  Albendazole                          Neutropenia
                                   Benznidazole                         Bone marrow suppression.
                                   Fumagillin (investigational)         Oral therapy: neutropenia, thrombocytopenia.
                                                                        Ocular therapy: minimal systemic effect or local effect
                                   Miltefosine                          Leukocytosis, thrombocytosis.
             Treatment for syphilis  Pentavalent antimony (sodium stibogluconate)  Leukopenia, anemia, thrombocytopenia
                                   Penicillin G                         Bone marrow suppression (rare), drug fever
             G6PD, Glucose-6-phosphate dehydrogenase.


             TABLE   Etiology of Anemia in Human Immunodeficiency Virus  assays) may be more reflective of serum B 12  status in neutropenic HIV
              157.5                                               infected patients.
                                                                    A diagnosis of B 12  deficiency should include not only a low serum
             HIV Related:
             HIV Infection:                                       B 12  level, but normal or elevated blood levels of folic acid, elevated
             Anemia of chronic disease                            blood  homocysteine,  and  elevated  methylmalonic  acid  levels  in  a
                                                                  patient with normal renal function. With a diagnosis of B 12  deficiency,
             Blunted production/response to erythropoietin        an effort should be made to determine the causes of B 12  malabsorp-
             Suppression of CFU-GEMM (HIV/inflammatory cytokines)  tion, and treatment begun with monthly administration of parenteral
             Neoplasms Infiltrating BM:                           B 12  to correct the deficiency. If anemia and cytopenias result from the
             Non-Hodgkin lymphoma, KS, Hodgkin lymphoma           B 12  deficiency alone, treatment should result in correction within 4
             Infections of the BM:                                to 6 weeks. Because B 12  deficiency is also associated with a variety of
             Parvovirus B19                                       neurologic defects, including motor and sensory neuropathy, cogni-
             Atypical mycobact (MAI/MAC)                          tive  defects  including  dementia,  and  the  most  severe  neurologic
             M. TB                                                manifestation of subacute combined degeneration of the spinal cord,
             Histoplasma                                          the possibility of B 12  deficiency should be considered in any HIV-
             CMV                                                  infected patient with neurologic symptoms.
             Medications Causing         Medications Causing Hemolysis:
             Decreased Production:
             RT inhibitors               Indinavir                Anemia Resulting From Increased Red Blood  
             Ganciclovir                 Bactrim and Dapsone in   Cell Destruction
             Bactrim                       G6PD deficiency
             Amphotericin B                                       Anemia resulting from hemolysis of RBCs can result from processes
             HIV Unrelated                                        either intrinsic or extrinsic to the RBC. Examples of intrinsic defects
             B 12  and/or folic acid deficiencies                 include  hemoglobinopathies,  RBC  membrane  defects,  or  RBC
             Iron deficiency caused by chronic blood loss         enzyme functional deficiencies such as glucose-6-phosphate dehydro-
                                                                  genase (G6PD) deficiency. Exclusive of G6PD deficiency, the major-
             BM, Bone marrow; CFU-GEMM, colony-forming unit–granulocyte, erythrocyte,
             macrophage, megakaryocyte; CMV, cytomegalovirus; G6PD, glucose-6-  ity  of  patients  with  these  RBC  defects  have  a  life-long  history  of
             phosphate dehydrogenase; HIV, human immunodeficiency virus; KS, Kaposi   anemia.  Diagnosis  in  most  circumstances  can  be  made  by  careful
             sarcoma; MAC, Mycobacterium avium complex; MAI, mycobacterium   review of the peripheral blood smear. G6PD deficiency is an X-linked
             avium-intracellulare; M. TB, Mycobacterium tuberculosis, RT, reverse   disorder and found predominantly in men. Hemolysis occurs when
             transcriptase.
                                                                  erythrocytes  are  exposed  to  oxidative  stress.  Depending  upon  the
   2543   2544   2545   2546   2547   2548   2549   2550   2551   2552   2553